Latest news with #LawOfficesof
Business Wire
19-05-2025
- Business
- Business Wire
Deadline Approaching: Elevance Health, Inc. (ELV) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Elevance Health, Inc. ('Elevance' or the 'Company') (NYSE: ELV) common stock between April 18, 2024, and October 16, 2024, inclusive (the 'Class Period'). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ELEVANCE HEALTH, INC. (ELV), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@ by telephone at (215) 638-4847 or visit our website at What Happened? On July 17, 2024, Elevance disclosed that it was 'expecting second-half utilization to increase in Medicaid' and that it was 'seeing signs of increased utilization across the broader Medicaid population, including in outpatient home health, radiology, durable medical equipment, as well as some elective procedures.' On this news, Elevance's stock price fell $32.21, or 5.8%, to close at $520.93 per share on July 17, 2024, thereby injuring investors. Then, on October 17, 2024, Elevance released its third quarter 2024 financial results, missing EPS consensus estimates by 13.7% 'due to elevated medical costs in [its] Medicaid business.' Additionally, the Company lowered its EPS guidance for 2024 by 11.3%. On this news, Elevance's stock price fell $52.61, or 10.6%, to close at $444.35 per share on October 17, 2024, thereby injuring investors further. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) sicker patients with higher acuity tended to remain on Medicaid after redetermination, leading to higher per-patient costs; (2) this increase in cost was occurring at a rate that was not adequately reflected in Elevance's rate negotiations with the states or in its financial guidance for 2024; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired Elevance common stock during the Class Period, you may move the Court no later than July 11, 2025 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. Contact Us To Participate or Learn More: If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Telephone: (215) 638-4847 Email: howardsmith@ Visit our website at: To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Business Wire
08-05-2025
- Business
- Business Wire
Bausch + Lomb Corporation (BLCO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Bausch + Lomb Corporation ('BLCO' or the 'Company') (NYSE: BLCO) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BAUSCH + LOMB CORPORATION (BLCO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@ by telephone at (215) 638-4847 or visit our website at What Happened? On March 27, 2025, BLCO disclosed that it had '[begun] to see an increased number of reports of toxic anterior segment syndrome (TASS) in conjunction with enVista® intraocular lenses (IOLs)' and was voluntarily recalling all of its enVista Envy and enVista Aspire IOLs, as well as enVista monofocal lenses. On this news, BLCO's stock price fell $1.54, or 9.8%, over two consecutive trading days to close at $14.13 per share on March 28, 2025, thereby injuring investors. Then, on April 30, 2025, BLCO released its first quarter 2025 financial results, disclosing that 'as enVista ramps back up, for the full year 2025, [it] estimate[s] one-time recall headwinds of approximately $55 million to revenue and $65 million to adjusted EBITDA.' On this news, BLCO's stock price fell $2.16, or 15.7%, to close at $11.56 per share on April 30, 2025, thereby injuring investors further. Contact Us To Participate or Learn More: If you purchased BLCO securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Telephone: (215) 638-4847 Email: howardsmith@ Visit our website at: This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Business Wire
08-05-2025
- Business
- Business Wire
Cytokinetics, Incorporated (CYTK) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Cytokinetics, Incorporated ('Cytokinetics' or the 'Company') (NASDAQ: CYTK) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CYTOKINETICS, INCORPORATED (CYTK), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@ by telephone at (215) 638-4847 or visit our website at What Happened? On May 1, 2025, Cytokinetics disclosed that the FDA has extended the review period for its cardiac myosin inhibitor drug, aficamten, by three months, citing additional time required to review newly submitted Risk Evaluation and Mitigation Strategy (REMS). The Company further revealed that, 'following pre-NDA discussions with FDA in which safety and risk mitigation were discussed, Cytokinetics submitted the NDA for aficamten in oHCM without an accompanying REMS.' On this news, Cytokinetics's stock price fell $5.57, or 12.9%, to close at $37.35 per share on May 2, 2025, thereby injuring investors. Contact Us To Participate or Learn More: If you purchased Cytokinetics securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Telephone: (215) 638-4847 Email: howardsmith@ Visit our website at: This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Business Wire
21-04-2025
- Business
- Business Wire
Deadline Approaching: Treace Medical Concepts, Inc. (TMCI) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Treace Medical Concepts, Inc. ('Treace Medical' or the 'Company') (NASDAQ: TMCI) securities between May 8, 2023 and May 7, 2024, inclusive (the 'Class Period'). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN TREACE MEDICAL CONCEPTS, INC. (TMCI), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@ by telephone at (215) 638-4847 or visit our website at What Happened? On May 7, 2024, after market hours, Treace Medical released its first quarter 2024 financial results and revised its full year 2024 guidance, lowering it by approximately $20 million, citing "increased use of MIS Osteotomy solutions and more competition from knockoffs of [the Company's] Lapiplasty products." On this news, Treace Medical's stock price fell $6.95, or 62.5%, to close at $4.17 per share on May 8, 2024, thereby injuring investors. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System (the 'Lapiplasty'); (2) as a result, Treace Medical's revenue declined and the Company needed to accelerate its plans to offer a product that was an alternative to osteotomy (a surgical procedure that involves cutting and realigning a bone to improve its position or function); and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired Treace Medical securities during the Class Period, you may move the Court no later than June 10, 2025 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. Contact Us To Participate or Learn More: If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Telephone: (215) 638-4847 Email: howardsmith@ Visit our website at: To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Yahoo
05-04-2025
- Yahoo
If a car accident revealed a brain tumor, would you still be happy? This man is
Chris Owens is used to fighting. As a poet, he fights for attention, giving everyday people a voice for the struggles and obstacles that make their lives more difficult than they should be. As an activist, he fights for equality, organizing voting drives and panel discussions to make sure people know what's going on and what they can do to change it. And as an entrepreneur, he fights for opportunity, using his 14-month-old co-working space CultureHUB as a place to connect small business owners with the resources and contacts to make their dreams come true. Now, he's fighting for his life, but he's not complaining. 'Repeat after me,' he wrote in a lengthy Facebook post. ''Today and every day, I choose JOY.'' He told me in a phone interview that he feels driven by a sense of purpose. He wants to be around for his partner, Lauren Malone, and their 3-year-old son. And he's still got work to do in trying to help more minorities in Arizona get themselves into the middle class. 'I've never really invested in the defeatist mentality,' he said. 'We all have things that happen to us. That doesn't mean we ignore it … I grew up in a Baptist church and was always instilled with stories of overcoming.' Owens has a tumor at the base of his brain, and it looks like surgeons are going to need to remove it. 'If it goes untreated, it would definitely be a problem,' he said. He's lucky to even know it's there. Owens was rear-ended by a hit-and-run driver in Phoenix last November. Owens said his vehicle was struck so hard that he was pushed from behind a crosswalk into the middle of an intersection on Van Buren Street. 'The accident left me with a cracked shoulder, torn labrum, whiplash, migraines, and debilitating pain that prevented me from walking (even WITH medication) until Christmas Eve, missing many opportunities including celebrating CultureHUB's one-year anniversary,' Owens wrote on Facebook. 'I'm still in physical therapy and will be for some time … and that's been the easy part.' He was put through a CT scan after the accident, and that's where doctors found the tumor. '(My endocrinologist told me), 'Don't forget,'' Owens wrote, ''at any point, if you're sitting or laying down at home, and it suddenly feels like an anvil hit you on your head, that means your brain is bleeding and you need to go to the ER immediately.'' His life has been a blur of doctor's appointments and physical therapy sessions, along with running a business and trying to be a good partner and father. There's no way he could have gotten through the last five months without his lady. 'Lauren has been incredible,' Owens said. The accident came as Malone was stepping full-time into entrepreneurship, leaving a 9-to-5 job as a law clerk to devote herself to the Law Offices of Lauren A. Malone, a trademark and copyright firm. 'There's been a lot of adjusting,' Malone said. 'Adjusting to his limitations, doctor's appointments … It's adjusted my schedule as well, since we're going through this together.' Malone has had to help out in a million ways, since Owens has a fraction of the energy he's known for, at best. Some days, he struggles to get out of bed. 'I want to help with CultureHUB however I can,' Malone said. 'Just to try to lighten the load.' Oddly, the experience is drawing them together. 'Yes, I feel like it has brought us closer,' Malone said. She explained that Owens has been able to advise her, leaning on his entrepreneurial experience. 'It's brought us closer in the sense of really, truly being there to support one another,' Malone said. Opinion: Help! I'm a single dad trying to survive spring break They're now focused on keeping CultureHUB in business. It's at risk of shutting down. 'So, here I am. My entire life I've worked on and with causes and events that give back to many communities, and now I am asking those communities for help while I battle and recover,' Owens wrote. 'I am working to raise $75,000 to cover past and future rent plus expenses … This goal may seem daunting to some, but I am blessed to have a big, diverse community filled with people who routinely make the impossible inevitable.' So far, he's raised about $1,000 from a dozen small donations. I'm certain, however, that of all the pastors, politicians and business leaders who've toured his space, gladhanding and promising support, Owens should be able to raise what he needs. And if they can't do it, maybe a few prominent athletes or celebrities can find a way to chip in. However, it works, this space, and the couple who run it, are too important to abandon during a time of need. Owens and Malone are optimistic, choosing joy over everything else. 'If everything goes well,' Malone said, 'I think on the other side things are going to be great … he can get back to business of making CultureHUB thrive.' To donate, visit: Reach Moore at gmoore@ or 602-444-2236. Follow him on X, formerly Twitter, @SayingMoore. Like this column? Get more opinions straight into your email inbox by signing up for our free opinions newsletter, which publishes Monday through Friday. This article originally appeared on Arizona Republic: Brain tumor changed his life. In some ways, for the better | Opinion
